Govt move of taxing life-saving drugs may boost domestic cos

The Indian pharma sector is split down the middle on the government's decision to hike customs duty on 76 life-saving drugs. While many companies slammed the hike in duties, quiet a few say the hike will not result in a rise in drug prices and their own counterparts in the industry say this is a knee-jerk reaction. Indian drug associations say that this hike, which is essentially a withdrawal of exemptions, will have a marginal impact on prices. CNBC-TV18's Archana Shukla explores this contrarian view.Watch video for more